Depression and Health Outcomes in Refractory Epilepsy
Completed · Phase 3
Conditions studied: Depression, Epilepsy
In brief
To define the benefits of antidepressant treatment or cognitive behavior therapy on mood, function, and quality of life in persons with depression and refractory epilepsy.
Key facts
- Study ID
- NCT00026637
- Run by
- Columbia University
- People needed
- 140
- Starts
- 2001-08-01
- Expected to finish
- 2008-06-01
- Last updated by the study team
- 2017-11-06
Who can join
Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Washington University School of Medicine — St Louis, Missouri, United States
- Columbia University Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.